Literature DB >> 20023061

Slackia piriformis sp. nov. and Collinsella tanakaei sp. nov., new members of the family Coriobacteriaceae, isolated from human faeces.

Fumiko Nagai1, Yohei Watanabe1, Masami Morotomi1.   

Abstract

Three Gram-positive, strictly anaerobic, non-spore-forming, rod-shaped organisms (strains YIT 12062(T), YIT 12063(T) and YIT 12064) were isolated from human faeces. Strain YIT 12062(T) was asaccharolytic and possessed a DNA G+C content of 58.3 mol%. Cells of strain YIT 12062(T) were negative for catalase, oxidase, urease, hydrolysis of aesculin and gelatin, nitrate reduction and indole production. Based on 16S rRNA gene sequence analysis, strain YIT 12062(T) was assigned to the genus Slackia (91.7-96.0 % sequence similarities to type strains of Slackia species). Biochemical data showed that the isolate was phenotypically distinct from all recognized species of the genus Slackia. Strain YIT 12062(T) therefore represents a novel species in the genus Slackia, for which the name Slackia piriformis sp. nov. is proposed. The type strain is YIT 12062(T) (=DSM 22477(T)=JCM 16070(T)). Following 16S rRNA gene sequence analysis, strains YIT 12063(T) and YIT 12064, which were isolated from different subjects, were shown to be most closely related to species of the genus Collinsella (93.8-95.1 % similarities to type strains). Although their phenotypic characteristics were very similar and they shared >99 % 16S rRNA gene sequence similarity and >97±1.8 % DNA-DNA relatedness, the two isolates could be discriminated by RAPD fingerprints. The DNA G+C contents of strains YIT 12063(T) and YIT 12064 were 60.8 and 61.0 mol%, respectively. They were saccharolytic in API test systems, positive for aesculin hydrolysis and negative for catalase, oxidase, urease, indole production, nitrate reduction and gelatin hydrolysis. The major end products of glucose fermentation of these strains were lactate, acetate and formate. Biochemical data supported the affiliation of strains YIT 12063(T) and YIT 12064 to the genus Collinsella and showed that they were phenotypically distinct from all recognized species of the genus Collinsella. Strains YIT 12063(T) and YIT 12064 therefore represent a novel species of the genus Collinsella, for which the name Collinsella tanakaei sp. nov. is proposed. The type strain is YIT 12063(T) (=DSM 22478(T)=JCM 16071(T)).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20023061     DOI: 10.1099/ijs.0.017533-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  17 in total

1.  Characterization of Phascolarctobacterium succinatutens sp. nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces.

Authors:  Yohei Watanabe; Fumiko Nagai; Masami Morotomi
Journal:  Appl Environ Microbiol       Date:  2011-11-11       Impact factor: 4.792

2.  Identification of an enzyme system for daidzein-to-equol conversion in Slackia sp. strain NATTS.

Authors:  Hirokazu Tsuji; Kaoru Moriyama; Koji Nomoto; Hideyuki Akaza
Journal:  Appl Environ Microbiol       Date:  2011-12-16       Impact factor: 4.792

3.  Collinsella ihumii sp. nov., a new anaerobic bacterium isolated from human stool.

Authors:  Mariem Ben Khedher; Fatou Samba Diouf; Cheikh Ibrahima Lo; Stéphane Alibar; Guillaume Durand; Didier Raoult; Pierre-Edouard Fournier; Florence Fenollar
Journal:  Arch Microbiol       Date:  2021-10-09       Impact factor: 2.552

Review 4.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Authors:  Christian Milani; Sabrina Duranti; Francesca Bottacini; Eoghan Casey; Francesca Turroni; Jennifer Mahony; Clara Belzer; Susana Delgado Palacio; Silvia Arboleya Montes; Leonardo Mancabelli; Gabriele Andrea Lugli; Juan Miguel Rodriguez; Lars Bode; Willem de Vos; Miguel Gueimonde; Abelardo Margolles; Douwe van Sinderen; Marco Ventura
Journal:  Microbiol Mol Biol Rev       Date:  2017-11-08       Impact factor: 11.056

5.  Characterization of Slackia exigua isolated from human wound infections, including abscesses of intestinal origin.

Authors:  Keun-Sung Kim; Marie-Claire Rowlinson; Robert Bennion; Chengxu Liu; David Talan; Paula Summanen; Sydney M Finegold
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

Review 6.  The Role of Microbiota in Infant Health: From Early Life to Adulthood.

Authors:  Yao Yao; Xiaoyu Cai; Yiqing Ye; Fengmei Wang; Fengying Chen; Caihong Zheng
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

7.  Regional Variation of CH4 and N2 Production Processes in the Deep Aquifers of an Accretionary Prism.

Authors:  Makoto Matsushita; Shugo Ishikawa; Kazushige Nagai; Yuichiro Hirata; Kunio Ozawa; Satoshi Mitsunobu; Hiroyuki Kimura
Journal:  Microbes Environ       Date:  2016-09-03       Impact factor: 2.912

8.  'Collinsella phocaeensis' sp. nov., 'Clostridium merdae' sp. nov., 'Sutterella massiliensis' sp. nov., 'Sutturella timonensis' sp. nov., 'Enorma phocaeensis' sp. nov., 'Mailhella massiliensis' gen. nov., sp. nov., 'Mordavella massiliensis' gen. nov., sp. nov. and 'Massiliprevotella massiliensis' gen. nov., sp. nov., 9 new species isolated from fresh stool samples of healthy French patients.

Authors:  S Ndongo; F Cadoret; G Dubourg; J Delerce; P-E Fournier; D Raoult; J-C Lagier
Journal:  New Microbes New Infect       Date:  2017-03-04

9.  Non-contiguous finished genome sequence and description of Collinsella massiliensis sp. nov.

Authors:  Roshan Padmanabhan; Gregory Dubourg; Thi-Thien Nguyen; Carine Couderc; Morgane Rossi-Tamisier; Aurelia Caputo; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2014-03-15

10.  Comparison of Different Strategies for Selection/Adaptation of Mixed Microbial Cultures Able to Ferment Crude Glycerol Derived from Second-Generation Biodiesel.

Authors:  C Varrone; T M B Heggeset; S B Le; T Haugen; S Markussen; I V Skiadas; H N Gavala
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.